BPC
MRK icon

Bearing Point Capital’s Merck MRK Stock Holding History

Bearing Point Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+1,620
New +$190K 0.03% 196
2025
Q1 		– Sell
-2,530
Closed -$252K – 167
2024
Q4 		$252K Buy
+2,530
New +$261K 0.05% 146

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bearing Point Capital's MRK Position: Q2 2026 in Review

Bearing Point Capital opened a new position in Merck (MRK) in Q2 2026: 1,620 shares worth $208K. The stake represents 0.03% of the portfolio and ranks #196 among its holdings. This is a return to the name: Bearing Point Capital previously reported a position in MRK as recently as Q4 2024.

Bearing Point Capital first reported a position in MRK in Q4 2024 and has held it in 2 quarters since. The position peaked at $252K in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bearing Point Capital held 1,620 shares of Merck worth $208K as of Q2 2026.
  • Merck was a new Bearing Point Capital position in Q2 2026.
  • Merck made up 0.03% of Bearing Point Capital's portfolio in Q2 2026, its #196 holding.
  • Bearing Point Capital first reported a position in Merck in Q4 2024 and has held it in 2 quarters since.
  • Bearing Point Capital's Merck position peaked at $252K in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bearing Point Capital's 13F filing for Q2 2026, filed 11 Aug 2026.